Attached files
| file | filename |
|---|---|
| EX-32 - PROVECTUS BIOPHARMACEUTICALS, INC. | ex32.htm |
| EX-31.2 - PROVECTUS BIOPHARMACEUTICALS, INC. | ex31-2.htm |
| EX-31.1 - PROVECTUS BIOPHARMACEUTICALS, INC. | ex31-1.htm |
| 10-K - PROVECTUS BIOPHARMACEUTICALS, INC. | form10-k.htm |
Exhibit 23.1
Consent of Marcum LLP
Independent Registered Public Accounting Firm’s Consent
We consent to the incorporation by reference in the Registration Statement of Provectus Biopharmaceuticals, Inc. (the “Company”) on Form S-3 (File No. 333-205704) of our report, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, dated March 22, 2018, with respect to our audits of the consolidated financial statements of Provectus Biopharmaceuticals, Inc. as of December 31, 2017 and 2016 and for each of the two years in the period ended December 31, 2017, which report is included in this Annual Report on Form 10-K of Provectus Biopharmaceuticals, Inc. for the year ended December 31, 2017.
/s/ Marcum llp
Marcum llp
New York, NY
March 22, 2018